APA
Ajmani A. K., Agrawal A., Prasad B. L. N., Basu I., Shembalkar J., Manikanth N., Subrahmanyam K. A. V., Srinivasa M., Chawla M., Srivastava M. K., Jebasingh F., Achappa B., Agrawal R. P., Pulichikkat R. K., Meena R., Bhatia S., Gupta S. K., Dange A., Srivastava A., Trailokya A., Shahavi V. & Shende S. (20200220). Efficacy and safety of evogliptin versus sitagliptin as an add-on therapy in Indian patients with type 2 diabetes mellitus inadequately controlled with metformin: A 24-week randomized, double-blind, non-inferiority, EVOLUTION INDIA study. : Diabetes research and clinical practice.
Chicago
Ajmani Ajay Kumar, Agrawal Aparna, Prasad B L N, Basu Indraneel, Shembalkar Jayashree, Manikanth Neeraj, Subrahmanyam K A V, Srinivasa M, Chawla Manoj, Srivastava Manoj Kumar, Jebasingh Felix, Achappa Basavaprabhu, Agrawal R P, Pulichikkat Rakesh K, Meena Ramdhan, Bhatia Shailaja, Gupta Sandeep Kumar, Dange Amol, Srivastava Ambrish, Trailokya Abhijit, Shahavi Vinayaka and Shende Sachin. 20200220. Efficacy and safety of evogliptin versus sitagliptin as an add-on therapy in Indian patients with type 2 diabetes mellitus inadequately controlled with metformin: A 24-week randomized, double-blind, non-inferiority, EVOLUTION INDIA study. : Diabetes research and clinical practice.
Harvard
Ajmani A. K., Agrawal A., Prasad B. L. N., Basu I., Shembalkar J., Manikanth N., Subrahmanyam K. A. V., Srinivasa M., Chawla M., Srivastava M. K., Jebasingh F., Achappa B., Agrawal R. P., Pulichikkat R. K., Meena R., Bhatia S., Gupta S. K., Dange A., Srivastava A., Trailokya A., Shahavi V. and Shende S. (20200220). Efficacy and safety of evogliptin versus sitagliptin as an add-on therapy in Indian patients with type 2 diabetes mellitus inadequately controlled with metformin: A 24-week randomized, double-blind, non-inferiority, EVOLUTION INDIA study. : Diabetes research and clinical practice.
MLA
Ajmani Ajay Kumar, Agrawal Aparna, Prasad B L N, Basu Indraneel, Shembalkar Jayashree, Manikanth Neeraj, Subrahmanyam K A V, Srinivasa M, Chawla Manoj, Srivastava Manoj Kumar, Jebasingh Felix, Achappa Basavaprabhu, Agrawal R P, Pulichikkat Rakesh K, Meena Ramdhan, Bhatia Shailaja, Gupta Sandeep Kumar, Dange Amol, Srivastava Ambrish, Trailokya Abhijit, Shahavi Vinayaka and Shende Sachin. Efficacy and safety of evogliptin versus sitagliptin as an add-on therapy in Indian patients with type 2 diabetes mellitus inadequately controlled with metformin: A 24-week randomized, double-blind, non-inferiority, EVOLUTION INDIA study. : Diabetes research and clinical practice. 20200220.